文献速递其他结缔组织病

全身型幼年特发性关节炎复合疾病活动度评分(sJADAS)的研制与初步验证

Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

本研究在10个国家30个中心纳入163例全身型幼年特发性关节炎(sJIA)患者,在原始JADAS四项基础上增加一个量化全身症状活动的第五项,构建sJADAS并检验其信效度。结果显示sJADAS可行、结构效度良好、内部一致性满意(Cronbach's α 0.64–0.65)、区分能力尚可且反应度强(标准化反应均数2.04–2.58),总体优于原始JADAS、类风湿关节炎DAS及成人Still病Puchot评分。

要点

  • sJADAS在原始JADAS四项基础上增加全身症状活动度一项,形成复合评分。
  • 在163例sJIA患者中显示可行、结构效度良好、反应度强。
  • 内部一致性Cronbach's α为0.64–0.65,区分能力尚可。

核心结论

  • sJADAS具有良好的测量学性能,可作为评估sJIA患儿疾病活动度的有效工具。
  • 新工具的表现需在其他前瞻性评估的患者队列中进一步检验。

研究设计与样本

  • 在10个国家30个中心纳入163例确诊或疑似sJIA患者,于初诊或复发时入组且存在活动性全身表现(应包括发热)。
  • 在基线后2周至3个月复评,检验含ESR、含CRP或不含急性期反应物三个版本。

主要发现

  • sJADAS可行,具有表面效度和内容效度、良好的结构效度,内部一致性满意(Cronbach's α 0.64–0.65)。
  • sJADAS能区分不同疾病活动状态及父母对疾病结局满意与否(两者P < 0.0001)。
  • sJADAS对随时间变化反应度强(标准化反应均数2.04–2.58)。
  • sJADAS总体测量性能优于原始JADAS、类风湿关节炎DAS及成人Still病Puchot评分。

关键数值与推荐

  • sJADAS由原始JADAS四项加一个量化全身症状活动的第五项构成。
  • 检验三个版本:含ESR、含CRP或不含急性期反应物。
  • 内部一致性Cronbach's α 0.64–0.65;标准化反应均数2.04–2.58。

临床怎么用

  • 可将sJADAS用于sJIA患儿疾病活动度的综合评估,兼顾关节与全身症状。
  • 临床可根据可用检测选择含ESR、含CRP或不含急性期反应物的版本。

局限性

  • 新工具的性能需在其他前瞻性评估的患者队列中进一步检验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To develop a composite disease activity score for systemic JIA (sJIA) and to provide preliminary evidence of its validity. METHODS: The systemic Juvenile Arthritis Disease Activity Score (sJADAS) was constructed by adding to the four items of the original JADAS a fifth item that aimed to quantify the activity of systemic features. Validation analyses were conducted on patients with definite or probable/possible sJIA enrolled at first visit or at the time of a flare, who had active systemic manifestations, which should include fever. Patients were reassessed 2 weeks to 3 months after baseline. Three versions were examined, including ESR, CRP or no acute-phase reactant. RESULTS: A total of 163 patients were included at 30 centres in 10 countries. The sJADAS was found to be feasible and to possess face and content validity, good construct validity, satisfactory internal consistency (Cronbach's alpha 0.64-0.65), fair ability to discriminate between patients with different disease activity states and between those whose parents were satisfied or not satisfied with illness outcome (P < 0.0001 for both), and strong responsiveness to change over time (standardized response mean 2.04-2.58). Overall, these properties were found to be better than those of the original JADAS and of DAS for RA and of Puchot score for adult-onset Still's disease. CONCLUSION: The sJADAS showed good measurement properties and is therefore a valid instrument for the assessment of disease activity in children with sJIA. The performance of the new tool should be further examined in other patient cohorts that are evaluated prospectively.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Tibaldi J, Pistorio A, Aldera E, et al. Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis. Rheumatology (Oxford). 2020. PMID: 32829413. doi:10.1093/rheumatology/keaa240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。